Autolus Therapeutics PLC (AUTL) Stock Price, Quote, News & History

AUTLNASDAQ
$1.44
-0.09-5.88%
At close: Apr 24, 5:00 PM EST
$1.47
0.032.08%
After Hours: 5:51 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-283.57M
Investing Cash Flow (TTM)
158.46M
Financing Cash Flow (TTM)
-4.34M
Free Cash Flow (TTM)
-310.70M
Capital Expenditure (TTM)
-27.13M
Net Change in Cash (TTM)
-129.45M

Analyst Trends and Forecast

1
Jan
1
Feb
2
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$152.59M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
5.40
PB Ratio (TTM)
2.29
Earnings Yield % (TTM)
-70.59%
Earnings Yield % (FWD)
-79.08%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.67

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$104.13M
Debt to Equity
0.40
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.51
Close
$1.44
Volume / Avg.
1.37M / 1.61M
Day Range
$1.42 - $1.53
52 Wk Range
1.15 - 2.70
Market Cap
$391.23M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
48
Short Interest
8.23%
Days to Cover
10.38

About

Sector
Health Care
Industry
Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUT...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Autolus Therapeutics (AUTL) stock?

A

You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Autolus Therapeutics (AUTL) competitors?

A

There are no as such competitors for Autolus Therapeutics.

Q

What is the forecast, or price target, for Autolus Therapeutics (AUTL) stock?

A

Autolus Therapeutics has a consensus price target of $9.04.

Q

What is the current price for Autolus Therapeutics (AUTL)?

A

The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $1.47 last updated April 24, 2026 at 5:51 PM EDT.

Q

Does Autolus Therapeutics (AUTL) pay a dividend?

A

There are no upcoming dividends for Autolus Therapeutics.

Q

When is Autolus Therapeutics (NASDAQ:AUTL) reporting earnings?

A

Autolus Therapeutics does not have any upcoming earnings scheduled.

Q

Is Autolus Therapeutics (AUTL) going to split?

A

There is no upcoming split for Autolus Therapeutics.

Q

What sector and industry does Autolus Therapeutics (AUTL) operate in?

A

Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.